Skip to main content
RESMED INC logo

RESMED INC — Investor Relations & Filings

Ticker · RMD LEI · 254900O2VD7IQ5OGI615 ASX Manufacturing
Open in API
Filings indexed 1,641 across all filing types
Latest filing 2012-02-02 Interim / Quarterly Rep…
Country AU Australia
Listing ASX RMD

About RESMED INC

https://www.resmed.com

ResMed Inc. is a global leader in the development, manufacturing, and distribution of medical devices and cloud-based software solutions for the management of sleep-disordered breathing, chronic obstructive pulmonary disease, and other respiratory conditions. The company’s primary product portfolio includes continuous positive airway pressure (CPAP) devices, bilevel machines, and a variety of masks and accessories designed to improve patient adherence and comfort. ResMed distinguishes itself through its focus on digital health, offering integrated software platforms that enable remote patient monitoring and data-driven clinical insights for healthcare providers. Additionally, the company provides software-as-a-service (SaaS) solutions to support out-of-hospital care settings, including home health, hospice, and skilled nursing facilities, aiming to improve patient outcomes and reduce overall healthcare costs.

Recent filings

Filing Released Lang Actions
Form 10Q for QTR ended December 31, 2011 39 pages 1.5MB
Interim / Quarterly Report Classification · 100% confidence The document is titled '10-Q' and is a quarterly report filed pursuant to sections 13 or 15(d) of the Securities Exchange Act of 1934. It covers the quarterly period ended December 31, 2011. The text includes detailed financial statements such as condensed consolidated balance sheets, statements of income, cash flows, and notes to the financial statements. It also contains management's discussion and analysis, risk factors, legal proceedings, and other information typical of a quarterly report. The document length is substantial (15,000 characters), and it contains actual financial data and analysis, not just an announcement or certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q2 2012
2012-02-02 English
Change of Director`s Interest Notice 2 pages 21.1KB
Director's Dealing Classification · 100% confidence The document is a Form 4 filed with the United States Securities and Exchange Commission (SEC). Form 4 is used to report changes in beneficial ownership of company securities by insiders such as directors, officers, or significant shareholders. The document includes detailed tables of securities acquired or disposed of, transaction dates, and ownership information. This type of filing corresponds to insider trading or director dealings. It is not an annual report, earnings release, or any other financial report but specifically a report of personal share transactions by company directors and executives. Therefore, the correct classification is Director's Dealing (DIRS). The document length and content fully support this classification with high confidence.
2012-02-01 English
Record Financial Results for the Q/E December 31, 2011 4 pages 38.6KB
Earnings Release Classification · 95% confidence The document is a detailed announcement of quarterly and six-month financial results for ResMed Inc. It includes specific financial figures such as revenue, net income, earnings per share, expenses, and balance sheet data for the periods ended December 31, 2011, and comparative periods. The text also mentions a conference call to discuss these quarterly results, which is typical for earnings releases. The presence of condensed consolidated statements of income and balance sheets with unaudited financial data confirms this is a financial results announcement rather than a full annual report or interim report. The document is not a transcript of the call, nor is it a regulatory filing or a report publication announcement. Therefore, the most appropriate classification is Earnings Release (ER). Q2 2012
2012-01-26 English
Amendment to Credit Agreement 10 pages 83.0KB
Capital/Financing Update Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated January 25, 2012, by ResMed Inc. It reports the entry into a material definitive agreement, specifically a first amendment to an existing credit agreement increasing the revolving credit facility from $300 million to $400 million. The document includes the full text of the amendment agreement and signatures from the involved parties. There are no financial statements or quarterly/yearly financial results presented, nor is this a report of voting results, management changes, or legal proceedings. The content is focused on a financing agreement amendment, which fits the category of Capital/Financing Update filings. The document length is substantial (15,000 characters), and it contains the full amendment text, not just an announcement or a link to a report, so it is not a Report Publication Announcement or Regulatory Filing. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2012-01-26 English
RMD Announces changes to Conference Call details 1
Regulatory Filings Classification · 95% confidence The document is an announcement from ResMed about a change to the outside US dial-in number for a conference call and webcast to discuss the second quarter 2012 results. It mentions the date of the call, how to participate, and details about the replay availability. There is no actual financial data or detailed financial report included in the text. The document is primarily an announcement about the logistics of a conference call related to earnings results, not the earnings release itself or a transcript. Therefore, it fits best as a Call Transcript (CT) announcement or a Regulatory Filing (RNS). However, since it is not a transcript but an announcement about the call logistics, it is best classified as a Regulatory Filing (RNS) as a fallback for miscellaneous announcements that do not fit other categories.
2012-01-19 English
RMD Announces Conference Call to discuss2nd Qtr 2012 results 1
Regulatory Filings Classification · 90% confidence The document is an announcement of a conference call and webcast to discuss the company's second quarter 2012 financial results. It includes details about the timing of the call, how to participate, and replay information. There is no actual financial data or detailed report content included. The document is short (2235 characters) and serves as a notification for an upcoming earnings call rather than the call transcript itself or the earnings release. Therefore, it fits best under the category of Call Transcript (CT) if it were the transcript, but since it is only an announcement of the call, it is more appropriate to classify it as a Regulatory Filing (RNS) because it does not contain the transcript or the earnings release itself, nor is it a report publication announcement. However, given the options, the best fit is Regulatory Filings (RNS) as a general announcement of the call and webcast for earnings results.
2012-01-05 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.